U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1801del (p.Ile601fs) AND CFTR-related disorder

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 1, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001828595.1

Allele description [Variation Report for NM_000492.4(CFTR):c.1801del (p.Ile601fs)]

NM_000492.4(CFTR):c.1801del (p.Ile601fs)

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1801del (p.Ile601fs)
HGVS:
  • NC_000007.14:g.117591968del
  • NG_016465.4:g.131185del
  • NM_000492.4:c.1801delMANE SELECT
  • NP_000483.3:p.Ile601fs
  • LRG_663t1:c.1801del
  • LRG_663:g.131185del
  • NC_000007.13:g.117232022del
  • NM_000492.3:c.1801del
Protein change:
I601fs
Links:
dbSNP: rs1792031758
NCBI 1000 Genomes Browser:
rs1792031758
Molecular consequence:
  • NM_000492.4:c.1801del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
CFTR-related disorder (CFTR-RD)
Synonyms:
CFTR-related disorders; CFTR-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002080680Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Jul 1, 2019)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002080680.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 19, 2024